PRVA | Ticker Profile - Titan Protect

PRVA

Privia Health Group, Inc.

Healthcare · Health Information Services · NMS

$21.63

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$2.7B

Total market value of the company

Trailing P/E

127.88

Expensive — high growth expected

Forward P/E

19.96

Based on estimated future earnings — lower means cheaper

Rev Growth

+25.8%

Year-over-year revenue change

Profit Margin

1.0%

How much profit the company keeps from each dollar of revenue

ROE

3.6%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$31.00

+43% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 19 analysts covering this stock

About Privia Health Group, Inc.

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

https://www.priviahealth.com

Country: United States Employees: 1,226 Industry: Health Information Services

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

0.570

Good returns relative to risk taken

Kelly Fraction

0.0283

Modest edge detected — smaller position warranted

Calmar Ratio

0.558

Acceptable balance between returns and drawdown risk

Annual Return

14.8%

Historical annualised return based on price data

Max Drawdown

-26.6%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.97

Less volatile than the market — more defensive

52W High

$26.51

18% below the year high

52W Low

$18.77

15% above the year low

Avg Volume

919,229

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.3

Days it would take all short sellers to cover — higher means more crowded

Short % Float

4.0%

Low short interest — limited bearish positioning

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$0.17

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

1.12

Meaningful debt load — monitor closely

Current Ratio

1.61

Healthy liquidity position

Quick Ratio

1.55

Like current ratio but excludes inventory — stricter test

Gross Margin

10.0%

Revenue left after cost of goods — higher means pricing power

Operating Margin

1.2%

Profit from core operations before interest and tax

Free Cash Flow

$111M

Positive — the business generates more cash than it spends

Revenue (TTM)

$2.2B

Total revenue over the last 12 months

Net Income

$22M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$40.00

Target Median

$31.00

Target Low

$24.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go